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Background: Affective symptoms are associated with cognition in midlife and later life. 2 
However, the role of cardiometabolic risk in this association has not been examined.  3 
Aims: The aim of this research was to investigate how cardiometabolic risk contributes to 4 
associations between affective symptoms and midlife cognition. 5 
Method: Data were used from the National Child Development Study (NCDS), a sample of 6 
people born in Britain during one week in 1958. Affective symptoms were assessed at ages 7 
23, 33, and 42 and a measure of accumulation derived. A cardiometabolic risk score was 8 
calculated from nine cardiometabolic biomarkers at age 44. Measures of memory, verbal 9 
fluency, and information processing were available at age 50.  10 
Results: After accounting for missing data using multiple imputation, fully adjusted path 11 
models indicated significant indirect associations between affective symptoms and midlife 12 
immediate memory (β=-0.002, SE=0.001, p=.009), delayed memory (β=-0.002, SE=0.001, 13 
p=.02) and verbal fluency (β=-0.002, SE=0.001, p=.045) through cardiometabolic risk. 14 
Cardiometabolic risk did not predict subsequent affective symptoms or cognition at age 50. 15 
Conclusions: These findings suggest that cardiometabolic risk may play an important 16 
indirect role in the association between affective symptoms and cognitive function (memory 17 
and verbal fluency). Results contribute to understanding of biological mechanisms underlying 18 
associations between affective symptoms and cognitive ageing, which can have implications 19 
for early detection of, and intervention for, those at risk of poorer cognitive outcomes. 20 
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Affective problems, such as depressive and anxiety symptoms and disorders, are important 2 
predictors of poorer cognitive function (1), faster cognitive decline (2), and constitute a risk 3 
factor for dementia (3) in older age. Understanding the pathways linking affective problems 4 
to later cognitive decline and dementia is a key public health priority, with important 5 
implications for dementia prevention (4). Various biological mechanisms have been proposed 6 
to underlie associations between affective symptoms and cognitive ageing (5), but to date, 7 
few of these have been systematically tested. One plausible biological mechanism is the 8 
cardiometabolic pathway (5). Cardiometabolic risk is an umbrella term which encompasses a 9 
cluster of cardiovascular and metabolic conditions, including insulin resistance, obesity, 10 
hypertension, dyslipidemia, and atherosclerosis. A dose-response relationship has been found 11 
between severity of depression and cardiometabolic risk (5,6) and persistence of affective 12 
symptoms over the life course has been shown to be a strong predictor of midlife 13 
cardiometabolic risk in NCDS (7). There is also increasing evidence that cardiometabolic risk 14 
factors are associated with accelerated cognitive ageing (8). Despite this, no research has 15 
systematically investigated whether the cardiometabolic pathway contributes to the 16 
association between affective symptoms and cognitive ageing and precisely how this 17 
association may operate. In particular, it is unknown whether the cardiometabolic risk may 18 
act as an indirect pathway between affective symptoms and cognitive ageing (indicative of 19 
mediation), or alternatively as a common cause contributing to both affective symptoms and 20 
cognitive outcomes. Consequently, the aim of this research was to test whether and how 21 
cardiometabolic risk may contribute to associations between affective symptoms and 22 
cognitive outcomes. Specifically, this study aims to test: 1 if there is an indirect path between 23 
accumulating affective symptoms and cognitive outcomes via cardiometabolic risk, 24 
something which would possibly be suggestive of a mediational role; and 2: whether 25 
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cardiometabolic risk predicts both affective symptoms and cognitive function at age 50, 1 







Data were from the National Child Development Study (NCDS), a sample of 17,415 people 3 
born in England, Scotland, and Wales during one week in March 1958. Data have been 4 
collected from cohort members a total of 11 times at ages 0, 7, 11, 16, 23, 33, 42, 44, 46, 50, 5 
and 55. Comprehensive detail about the sample, data collection methods, and attrition rates 6 
are published elsewhere and are freely available online (9). Data were made available upon 7 
application by METADAC who manage genetic and biomedical data for NCDS. Written 8 
informed consent was obtained from all subjects/patients. Ethical approval for the present 9 
study was provided by the University of Sussex (ER/AJ316/2). 10 
Measures 11 
Cognitive outcomes 12 
Measures of immediate memory, delayed memory, verbal fluency, information processing 13 
speed, and information processing accuracy were available at age 50. Memory was assessed 14 
using a word list recall test, in which 10 words were presented visually and cohort members 15 
listed the words they could recall immediately after presentation and then again after a delay. 16 
Verbal fluency was assessed using the Animal Naming Task, in which cohort members listed 17 
as many animals as they could within a timed period. Information processing speed and 18 
accuracy were assessed using a letter cancellation task. The number of letters scanned within 19 
a timed period represented information processing speed, with number of errors made used as 20 
a measure of processing accuracy. Higher scores represent better performance for all 21 
cognitive outcomes, with the exception of information processing accuracy for which higher 22 
scores indicate more errors. These cognitive measures have been described in detail and are 23 
published elsewhere (10). 24 
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Affective symptoms 1 
Affective symptoms in adulthood were measured at age 23, 33, and 42 using the Malaise 2 
Inventory scale, a 24 item self-completion questionnaire (11). This is a measure of 3 
psychological distress, including emotional disturbance and related physical symptoms. 4 
There is a validated cut off for clinical relevance (used in this study). Cohort members 5 
scoring 8 and above out of 24, the validated threshold for clinical relevance (11). were coded 6 
as having case level affective symptoms (i.e. a high risk of depression), and those scoring 7 7 
and below were coded as having no symptoms. The Malaise Inventory Scale has been used 8 
frequently in previous research (7,12) and the internal consistency of this questionnaire is 9 
acceptable (11). In line with previous research (12), a measure of accumulating affective 10 
symptoms was derived by summing the binary malaise score at age 23, 33, and 42 to 11 
represent the number of time points through adulthood with case level affective symptoms 12 
(score range 0-3). 13 
Cardiometabolic risk 14 
At age 44, nine measures of cardiometabolic risk were assessed: 1. Total cholesterol; 2. High 15 
density lipoprotein (HDL) cholesterol – reverse scored; 3. Triglycerides; 4. Glycosylated 16 
hemoglobin (hba1c); 5. Systolic blood pressure; 6. Diastolic blood pressure; 7. C-Reactive 17 
Protein (CRP) (excluding values >10mg/l, which may be indicative of recent infection); 8. 18 
Fibrinogen; 9. Resting heart rate.  19 
HDL cholesterol was reverse scored, so that for all biomarkers higher scores represent greater 20 
cardiometabolic dysfunction. These biomarkers were selected based on the previous research 21 
examining cardiometabolic risk in NCDS (7). Specifically, each of these nine variables are 22 
components of cardiometabolic risk. Biochemical analyses of blood samples used to collect 23 
information on HbA1c, triglycerides, total and HDL cholesterol, fibrinogen, and CRP is 24 
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published elsewhere and is described in depth in the NCDS biomedical user guide and the 1 
technical report (13,14). 2 
These measures were used both as individual variables and to derive a composite measure of 3 
cardiometabolic risk. Measures of CRP and triglycerides were skewed in the direction of low 4 
risk and therefore were log transformed. Standardised z scores were derived for all 5 
biomarkers and then used in all subsequent analyses. As in previous work (7), z scores for 6 
each biomarker were summed to create an overall composite measure of cardiometabolic risk 7 
score. Higher scores on this derived measure represent greater cardiometabolic dysfunction. 8 
Covariates 9 
Covariates were selected based on variables known to be associated with cognitive function. 10 
Specifically, models were adjusted for sex (3), educational attainment (15), childhood 11 
socioeconomic position (16), childhood cognitive function (17), and affective symptoms 12 
contemporaneous with measurement of cognitive function (age 50). Education was measured 13 
as the highest academic achievement attained by age 50. This was classified into three 14 
categories: 1. No education; 2. GCSE to A-Level (or Scottish equivalent); 3. Higher 15 
education. Childhood socioeconomic position was derived according to guidelines from the 16 
Centre for Longitudinal Studies (CLS) (18), and was based on parental occupation and 17 
household tenure. This was coded into three categories: 1. Working class; 2. Intermediate 18 
class; 3. Middle class. Childhood cognitive function at age 11 was assessed using a general 19 
ability test (19), which cohort members completed at school. Affective symptoms at age 50 20 
were assessed using the short-form of the Malaise Inventory Scale, which encompassed nine 21 
items (20), as the 24 item measure is not available at this age. 22 
Analytical procedure 23 
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For main analyses, path models were run, estimating direct associations between 1 
accumulating affective symptoms and midlife cognitive function and indirect associations 2 
through the composite measure of cardiometabolic risk. The use of this composite score 3 
allows the model to take into account that combined small variations across multiple 4 
biomarkers can confer meaningful change in disease risk, regardless of the signal for any 5 
individual biomarker (21). 6 
Next, an additional analysis was run to test whether associations between affective symptoms 7 
and cognitive function are driven by cardiometabolic risk as a common cause mechanism. To 8 
test this, a path model was conducted using a cardiometabolic risk score to predict cognitive 9 
function and affective symptoms at age 50.  10 
Initial models were unadjusted and subsequent models were adjusted for the covariates. All 11 
cognitive measures were included together in the models to account for covariances between 12 
different cognitive domains. Non-significant covariances were removed from the model to 13 
improve fit. Stratifying analyses by sex did not significantly improve model fit 14 
(Supplementary Table 1), therefore sex was adjusted for in all subsequent models rather than 15 
used as a stratifying variable. Model fit was tested using standard fit statistics: Chi square 16 
goodness of fit test, Comparative Fit Index (CFI), Tucker Lewis Index (TLI) and Root Mean 17 
Square Error of Approximation (RMSEA). Missing data were accounted for using full 18 
information maximum likelihood (FIML) methods, in which model parameters and standard 19 
errors are estimated using all available data. All analyses were conducted in Mplus V8.(22) 20 
In order to maximize the analytic sample size, main models were rerun using multiple 21 
imputation to impute all covariate data. In total, 21 variables were imputed over five sweeps 22 
using the MICE package in R. Main models were re-run on the imputed dataset (N=9377). 23 
Supplementary analyses 24 
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To check whether indirect associations between affective symptoms and cognitive outcomes 1 
were driven primarily by any particular individual biomarker, an additional model was run in 2 
which the nine biomarkers were included in the model individually. This approach allows the 3 
effects of each biomarker to be estimated, while simultaneously accounting for covariances 4 
between these markers. Following relevant work in NCDS, sensitivity analyses were 5 





Missing data and descriptive statistics 2 
The biomedical sweep at age 44 included 9,377 participants. Of this sample, 3,730 people 3 
had complete information for all key variables and covariates (Supplementary Figure 1). This 4 
sub-sample was compared to the sample with missing data on key variables (Supplementary 5 
Table 2). This revealed that people with missing data had significantly poorer scores for all 6 
cognitive tests (including childhood) except processing speed; had reported more episodes of 7 
affective symptoms from age 23 to 42 and higher affective symptoms at age 50; were more 8 
likely to be categorized as working class, have lower education, and to take cardiovascular 9 
medication ; and showed significantly higher levels of all cardiometabolic biomarkers. 10 
However, there were no sex differences in probability of missing data. Missing data were 11 
addressed using FIML, resulting in an analytic sample of 6,405 people in fully adjusted 12 
models. Main models were also conducted on the imputed sample, resulting in a sample of 13 
9,377 in fully adjusted models. Demographic information is presented in Table 1. 14 
Research question 1: Indirect pathway model 15 
Both the unadjusted and adjusted FIML model fit the data well (Unadjusted: N=6682; 16 
χ2(1)=5.91, p=.02; CFI=1.00; TLI=0.99; RMSEA=0.03; Adjusted: N=6403; χ2(2)=1.24, 17 
p=.54; CFI=1.00; TLI=1.00; RMSEA=0.00). The model conducted on the imputed sample 18 
also fit to the data well (N=9377; χ2(2)=6.22, p=.04; CFI=1.00; TLI=0.99; RMSEA=0.02) 19 
Direct effects 20 
Unadjusted FIML models showed significant direct effects of accumulating affective 21 
symptoms across adulthood on midlife immediate memory (β=-0.09, SE=0.01, p<.001), 22 
delayed memory (β=-0.08, SE=0.01, p<.001), verbal fluency (β=-0.09, SE=0.01, p<.001), 23 
and information processing accuracy (β=0.05, SE=0.01, p<.001), but not for information 24 
11 
 
processing speed. However, there were no significant direct effects of affective symptoms on 1 
any cognitive domain after adjustment for all covariates (Table 2; Figure 1). Similarly, the 2 
fully adjusted model conducted on the imputed sample revealed no significant direct effects 3 
of affective symptoms on any cognitive domain (Table 2; Figure 1). 4 
Indirect effects 5 
In the unadjusted FIML model, there were significant indirect effects of affective symptoms 6 
on immediate memory, delayed memory, verbal fluency, and information processing speed 7 
operating through composite cardiometabolic risk score (immediate memory: β=-0.01, 8 
SE=0.002, p=.008; delayed memory: β=-0.01, SE=0.002 p=.008; verbal fluency: β=-0.003, 9 
SE=0.001, p=.01; information processing speed: β=-0.003, SE=0.001, p=.02). There was no 10 
effect for information processing accuracy. After adjustment for covariates, there was still a 11 
significant indirect effect of accumulating affective symptoms on immediate memory (β=-12 
0.002, SE=0.001, p=.02), accounting for 4% of the total effect (Table 2; Figure 1). The fully 13 
adjusted model run on the imputed sample revealed significant indirect effects of 14 
accumulating affective symptoms on immediate memory (β=-0.002, SE=0.001, p=.009), 15 
delayed memory (β=-0.002, SE=0.001, p=.02) and verbal fluency (β=-0.002, SE=0.001, 16 
p=.045), through the composite cardiometabolic risk score. This accounted for 4%, 4%, and 17 
5% of the total effect respectively. There were no significant indirect effects on information 18 
processing speed or accuracy (Table 2, Figure 1). 19 
Total effects 20 
In the unadjusted model, there were significant total effects of accumulating affective 21 
symptoms on immediate memory (β=-0.09, SE=0.01, p<.001), delayed memory (β=-0.08, 22 
SE=0.01, p<.001), verbal fluency (β=-0.09, SE=0.01, p<.001), and information processing 23 
accuracy (β=0.05, SE=0.01, p<.001), but not information processing speed. After adjusting 24 
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for covariates, significant total effects remained for immediate memory (β=-0.05, SE=0.01, 1 
p=.001), delayed memory (β=-0.05, SE=0.01, p<.001), and information processing accuracy 2 
(β=0.04, SE=0.01, p=.01), but not for verbal fluency or information processing speed (Table 3 
2; Figure 1). The adjusted model conducted on the imputed sample revealed significant total 4 
effects of accumulating affective symptoms on immediate memory (β=-0.05, SE=0.01, 5 
p<.001), delayed memory (β=-0.05, SE=0.01, p<.001), verbal fluency (β=-0.04, SE=0.01, 6 
p=.003) and information processing accuracy (β=0.04, SE=0.01, p=.01), but not on 7 
information processing speed (Table 2; Figure 1). 8 
Research question 2: Common cause model 9 
Next, a model was run using cardiometabolic risk score at age 44 as a predictor of affective 10 
symptoms and cognitive function at age 50 to test cardiometabolic risk as a potential common 11 
cause. The model fit the data well (N= 3847; χ2(18)=34.27, p=.01; CFI=1.00; TLI=0.99; 12 
RMSEA=0.02). Fully adjusted models revealed that cardiometabolic risk significantly 13 
predicted immediate memory (β=-0.04, SE=0.02, p=.008), but not other cognitive outcomes. 14 
Additionally cardiometabolic risk did not significantly predict affective symptoms at age 50 15 
(β=0.002, SE=0.01, p=.90) (Table 3). The adjusted model conducted on the imputed sample 16 
fit to the data well (N=5288; χ2(18)=36.23, p=.007; CFI=1.00; TLI=0.99; RMSEA=0.01). 17 
The analysis on imputed data revealed that cardiometabolic risk score at age 44 was 18 
significantly associated with poorer scores of immediate memory (β=-0.04, SE=0.02, 19 
p=.003), delayed memory (β=-0.03, SE=0.02, p=.048), and verbal fluency (β=-0.03, 20 
SE=0.02, p=.03) at age 50. However, cardiometabolic risk at age 44 was not significantly 21 
associated with affective symptoms at age 50 (β=0.02, SE=0.01, p=.24) (Table 3). 22 
Supplementary analysis 23 
13 
 
The model including nine individual biomarkers as predictors fit the data well (N=6405; 1 
χ2(12)=33.29, p<.001; CFI=1.00; TLI=0.99; RMSEA=0.02). In fully adjusted models 2 
including all covariates and individual cardiometabolic biomarkers, there were no significant 3 
direct effects of accumulating affective symptoms on cognitive outcomes. There was a 4 
significant indirect path between accumulating affective symptoms and delayed memory 5 
through fibrinogen (β=-0.003, SE=0.001, p=.03), accounting for 6% of the total effect. All 6 
other indirect paths were not significant at the 5% level in adjusted models. There were 7 
significant total effects of accumulating affective symptoms on immediate memory (β=-0.05, 8 
SE=0.01, p=.001), delayed memory (β=-0.05, SE=0.01, p<.001), and information processing 9 
accuracy (β=0.04, SE=0.01, p=.01), but not for verbal fluency or information processing 10 
speed (Supplementary Table 3). 11 
Additional analyses were conducted additionally adjusting for cardiovascular medication use. 12 
The model fit the data well (N= 6370; χ2(3)=12.12, p=.007; CFI=1.00; TLI=0.98; 13 
RMSEA=0.02). Results were largely identical to those reported in main models 14 






Summary of findings 2 
Results across models using two missing data methods (FIML and multiple imputation) both 3 
revealed significant indirect associations between accumulation of affective symptoms and 4 
immediate memory through a composite cardiometabolic risk score. Additionally, models 5 
using multiple imputation revealed significant indirect associations on delayed memory and 6 
verbal fluency. Additional associations may have been revealed in the model using imputed 7 
data due to extra power associated with increasing the sample size. There were no significant 8 
indirect paths observed between symptoms and other cognitive domains (information 9 
processing). These results build on previous research which show associations between affect 10 
and cardiometabolic risk, and also between cardiometabolic risk and cognitive outcomes 11 
(7,23) but had not investigated the role cardiometabolic risk might play in the known 12 
relationship between affect and later cognition. These results do not support the common 13 
cause hypothesis that cardiometabolic risk may precede both development of affective 14 
symptoms and cognitive dysfunction, because in this data cardiometabolic risk score did not 15 
predict subsequent level of affective symptoms. 16 
There are several plausible mechanisms, which may account for the observed associations. 17 
For example, accumulated affective symptoms may be associated with cardiometabolic risk 18 
due to behavioural/lifestyle factors with known associations to dementia and cognitive ageing 19 
(e.g. smoking, alcohol, physical activity) (24). Additionally, affective symptoms may be 20 
linked with cardiometabolic risk through biological pathways (e.g. through HPA 21 
dysregulation, inflammatory processes, sympathetic nervous system activity) (25), which can 22 
also be associated with later cognitive health. The mechanisms which underlie these observed 23 
associations are likely to be complex and multifaceted. 24 
15 
 
It should be noted that effect sizes are small and account for only small amounts of the total 1 
effects. This suggests that, cardiometabolic risk may be one of multiple underlying pathways 2 
and other lifestyle and biomedical factors are likely to play an important role within the 3 
association between affective symptoms and cognitive ageing. Further understanding these 4 
relationships may be important for appropriate targeting of intervention and advice for 5 
amelioration of cognitive risk in the context of high levels of affective symptoms,  6 
Strengths and limitations 7 
Strengths of this research include the use of a large nationally representative cohort, with 8 
prospective data available from birth through to midlife over a period of five decades. 9 
Additionally, the repeated use of the same instrument to capture affective symptoms over 10 
time is a strength of this study. Affective symptoms contemporaneous with cognitive function 11 
were included in the models, reducing the possibility that associations between affective 12 
symptoms and later cognitive function are simply due to cross sectional associations at age 13 
50. Limitations included missing data, a limitation of most long-running cohort studies. In 14 
this study, the sample with missing data differed significantly from the sample with complete 15 
information on a range of key variables, including cognitive scores, levels of affective 16 
symptoms, and demographic information. The sample with missing data showed higher 17 
affective symptoms, poorer cognitive function, and raised cardiometabolic symptoms, and as 18 
such associations may be underestimated in this analysis. To address this in these analyses, 19 
multiple imputation and FIML were used. It is important to note however that if data is 20 
missing not at random (MNAR), these methods may be less appropriate. Additionally, a 21 
further limitation of the study is that the number of individuals with case level affective 22 
symptoms is relatively small, which may lead to a possible underestimation of effects. 23 
16 
 
Additionally, cardiometabolic biomarkers were only measured at one time point (age 44). 1 
Therefore, the possibility of reverse causality cannot be ruled out. However, we ran a 2 
supplementary analysis to partially address this using cardiometabolic risk score as a 3 
predictor of later affective symptoms at age 50. These results showed that the association did 4 
not operate in the opposite direction and cardiometabolic risk did not predict subsequent 5 
affective symptoms. Furthermore, although we adjusted for cardiovascular medication use in 6 
a sensitivity analysis, there was no measure of psychotropic medication use, which was 7 
consequently not accounted for in the present analyses. Additionally, cognitive data were 8 
only available at one time point in this dataset at age 50, so it will be valuable to model 9 
cognitive trajectories in a future study. Related to this, it is currently unknown the extent to 10 
which midlife cognitive function in this cohort is relevant to dementia risk decades later. This 11 
can be tested in this cohort in the future with repeated follow-up assessment of cognitive 12 
function and dementia status as participants transition into older adulthood. Finally, the 13 
cognitive assessments were limited in breadth, meaning that conclusions cannot be drawn for 14 
other cognitive domains not measured in NCDS (e.g. executive functions).  15 
Future research and implications 16 
Overall, these findings provide strong evidence across two missing data methods that 17 
cardiometabolic health may contribute to the relationship between accumulating affective 18 
symptoms over adulthood and midlife immediate memory. The findings also provide 19 
preliminary evidence to suggest that cardiometabolic risk may also contribute to associations 20 
between affective symptoms and delayed memory and verbal fluency. Only a small amount 21 
of the total effect of affective symptoms on cognitive function was accounted for by the 22 
indirect effect through cardiometabolic risk. This suggests that cardiometabolic risk is likely 23 
one of multiple pathways operating in this association. Other potential pathways may involve 24 
17 
 
complex interactions between lifestyle and biological factors. Future research should aim to 1 
identify and test these mechanisms.  2 
Affective symptoms present during late life are considered a recognised risk factor for 3 
dementia. However, it remains unclear whether this represents a flare-up of earlier depressive 4 
symptoms and associated cardiometabolic risk, or whether affective symptoms later in the 5 
life course also have direct effects on dementia risk.  6 
These findings have potentially important implications for prevention, specifically the 7 
possibility that early intervention to improve cardiometabolic health in people with affective 8 
symptoms may help to prevent poorer cognitive outcomes later in the life course. Future 9 
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cognitive outcomes at age 50, via cardiometabolic risk. 









Sample in biomedical sweep of NCDS (N=9,377) 
N (%) Mean (SD) 
Immediate memory - 6.59 (1.48) 
Delayed memory - 5.47 (1.84) 
Verbal fluency - 22.43 (6.29) 
Information processing speed - 333.61 (88.01) 
Information processing accuracy - 4.32 (3.98) 
Number of time 
points with 
affective symptoms 
from age 23 to 42 
0 times 5754 (83.3) - 
1 time 781 (11.3 - 
2 times 266 (3.9) - 
3 times 105 (1.5) - 
Affective symptoms at age 50 - 1.44 (1.90) 
Sex (Female) 4712 (50.3) - 




Working 3238 (41.7) - 
Intermediate 2880 (37.1) - 




1323 (16.1) - 
GCSE to A Level (or 
Scottish equivalent) 
4781 (58.3) - 
Higher education 2091 (25.5) - 





Table 2: Adjusted models testing direct, indirect, and total associations between accumulating affective symptoms from age 23 to 42 and midlife 
cognitive outcomes at age 50, via cardiometabolic risk. 





FIML Model (N=6403; X2(2)=1.24, p=.54; CFI=1.00; TLI=1.00; RMSEA=0.00) 
Direct -0.02 (0.02), .17* -0.03 (0.02), .10 0.00 (0.02), .98 0.03 (0.02), .06 0.03 (0.02), .11 
Indirect -0.002 (0.001), .02 -0.001 (0.001), .10 -0.001 (0.001), .30 0.00 (0.001), .57 -0.001 (0.001), .23 
Total** -0.05 (0.01), .001 -0.05 (0.01), < .001 -0.02 (0.01), .15 0.02 (0.01), .15 0.04 (0.01), .01 
Multiple Imputation Model (N=9377; X2(2)=6.22, p=.04; CFI=1.00; TLI=0.99; RMSEA=0.02) 
Direct -0.03 (0.01), .09 -0.02 (0.01), .12 -0.02 (0.01), .19 0.03 (0.02), .10 0.02 (0.02), .16 
Indirect -0.002 (0.001), .009 -0.002 (0.001), .02 -0.002 (0.001), .045 -0.001 (0.001), .35 -0.001 (0.001), .53 
Total -0.05 (0.01), <.001 -0.05 (0.01), <.001 -0.04 (0.01), .003 0.02 (0.01), .14 0.04 (0.01), .01 
 
* β (SE), p. 
** Total effects include direct effects of affective symptoms on cognitive outcomes and indirect effects through cardiometabolic biomarkers and 
affective symptoms at age 50. 
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Figure 1: Path analysis models: Fully adjusted models showing direct, indirect, and total associations between accumulating affective symptoms 
from age 23 to 42 and midlife cognitive outcomes at age 50, via cardiometabolic risk. 
 
* Significant pathways in bold. Models using FIML and multiple imputation are both presented. 
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Table 3: Model using CMR score to predict affective symptoms and cognitive function at age 50. 
  
Model using FIML 
N = 3847; X2(18)=34.27, p=.01; CFI=1.00; 
TLI=0.99; RMSEA=0.02 
Model using multiple imputation 
N=5288; X2(18)=36.23, p=.007; CFI=1.00; 
TLI=0.99; RMSEA=0.01   
Affective symptoms age 50 0.002 (0.01), .90* 0.02 (0.01), .24 
Immediate memory -0.04 (0.02), .008 -0.04 (0.02), .003 
Delayed memory -0.02 (0.02), .24 -0.03 (0.02), .048 
Verbal fluency -0.01 (0.02), .45 -0.03 (0.02), .03 
Information processing speed 0.001 (0.02), .96 -0.01 (0.02), .73 
Information processing accuracy -0.02 (0.02), .37 -0.01 (0.02), .66 
 
*β (SE), p. 
 
 
 
 
